Fascia Clinics aims to be the first choice for individuals seeking well-being

Table of Contents

Franchise system within health

  • Tech/Health: Franchise system for the efficiency and automation of health clinics
  • Developed & tested: Established 18 clinics in two years, increasing from 1.7 million SEK in 2021 to 17.9 million SEK in 2023 with an EBITDA of 2.4 million SEK
  • Great potential with Fascia treatment: New research, growing trend & demand, effective treatment

Interest in fascia is growing – but why is fascia so interesting?

A two-minute film where world-leading researchers share their views on what Fascia is and why it is so fascinating.

Join the journey from idea to stock market listing & international expansion

Development 2010-2020

During the pandemic, the idea was born to combine products, services, concepts, and ten years of experience and insights into a new business idea – Fasciaklinikerna.

Startup 2021-2022

As a franchise concept, the path forward became clear, and with the first clinics established, the concept could be developed and tested.

2023-2024 Growth

The concept has been tested and works, more clinics are opening, and demand and profitability are increasing. The franchise clinics are becoming increasingly self-sufficient.

2025-2027 Expansion

A pre-IPO in spring 2025 and stock market listing in autumn 2025 will provide resources for international launch and national expansion. By 2027, 250 clinics will be operating in Sweden, and Fasciaklinikerna will generate 1 billion SEK in revenue.

Tech/Health: Efficiency & automation of health clinics

  • Central control system for marketing, booking, payment, accounting & administration
  • Simple key figures and central management maximize profitability & growth for the franchisee
  • Focus on treatment, customer care & continuing education increases customer satisfaction

Developed and tested

  • Idea, startup & development 2020-2021
  • Launch of franchise system 2022
  • Proof of concept 2022-2023

Great potential with Fascia treatment

New research on the body’s network & the flow around all cells

Increases performance, prevents injuries & improves recovery

Growing trend within wellness

Fascia: What & why?

  • What is Fascia? New research shows that fascia plays a more important role in health, pain, and discomfort than previously thought. Fascia is the network of connective tissue that surrounds everything in the body – from muscles and bones to organs and cells. It is the structure and flow between all cells that maintain connection, communication, and interaction between different parts of the body. Fascia is a living, vibrating, multidimensional, pressure-distributing network.
  • Why Fascia? Fascia is a way to explain how our body functions as a whole and why we are affected by so many different things. This enables a new way to assess a person’s health by looking at the whole and considering various aspects such as posture, balance, movement, lifestyle, nutrition, injuries, stress, thoughts, emotions, personal history, and trauma – everything that affects the fascia.
  • The fascia perspective is a way to treat the customer as a whole, taking everything into account and simultaneously knowing how to start adjusting the small things that have the greatest impact, helping the body to self-heal.

Scalable overall solution & happy customers B2C

Structured & proven treatment process

Unique fascia treatment with patented software

Nutritional supplements under own brand

Unique fascia treatment with patented software

  • Used in two internationally published research studies in 2015 & 2019
  • Award-winning, designed & manufactured in Sweden
  • Ensures the quality of the treatment process

Central management maximizes profitability & growth B2B

Standardized & scalable store concept

Training & ongoing continuing education

Cost-effective growth with processes & quality assurance

Proven & profitable business model

  • Application process & license fee
  • Central control system for marketing, booking, payment, accounting & administration
  • Franchise fee 15% of gross turnover
  • Central marketing fund 10% of gross turnover

Simple key figures facilitate for the franchisee

  • Turnover
  • Occupancy rate (opening hours)
  • Booking rate
  • Nutritional supplements/turnover
  • Growth rate customer base & members

First Mover Advantage within Fascia

  • Wellness is a rapidly growing market (8.6% CAGR)
  • Fascia is a new research field that addresses several verticals within the wellness industry
  • Target Sweden: Convert small independent wellness clinics to franchisees
  • Target Europe: Unique patented holistic solution & centrally controlled platform enable establishment within several verticals in the wellness industry & attract master franchisees (gym chains, spas, pharmacies)

Growth plan Sweden

  • Goal: A total of 72 clinics (start of 54 new)
  • Example: An increase from today’s 18 to 36 clinics increases EBITDA from 3.6 million SEK to 9.6 million SEK per year
  • Franchise and business automation provide economies of scale, operational synergies and leverage during expansion

Growth plan – Europe

Start first international clinic & prepare master franchise

License fee per region & royalties

Digital launch in multiple languages to capitalize on global interest

Central management maximizes profitability & growth

Forecast, key figures & history

Fasciaklinikerna SE20222023202420252026
Revenue7,9 MSEK16,7 MSEK20,7 MSEK32,8 MSEK51,8 MSEK
Operating costs– 4,8 MSEK– 12 MSEK– 15,7 MSEK– 24,7 MSEK– 39,7 MSEK
Other costs– 0,2 MSEK– 1,6 MSEK– 4 MSEK– 7 MSEK– 9,3 MSEK
Personell costs– 1,1 MSEK– 0,8 MSEK– 0,8 MSEK– 0,8 MSEK– 1,7 MSEK
EBITDA1,7 MSEK2,3 MSEK0,2 MSEK0,3 MSEK1,1 MSEK
      
New clinics61341010
Percentage increase 98%34%58,50%57,70%
      
FasciaClinics International20222023202420252026
Royalties Sweden  0,9 MSEK1,5 MSEK2,4 MSEK
License startup Spain   1 MSEK9 MSEK
Royalties Spain    0,5 MSEK

Capital needs – approximately 20 million SEK for the growth plan

  • 30% – Recruitment of key competencies
  • 15% – Expansion in Sweden
  • 55% – Digital launch EU & establishment in Spain

Structured process ahead of listing on Nasdaq First North Q2/Q3 2025

Board, management team and advisors

Stefan Sallerfors, Chairman

Doctor with a background in healthcare, the financial sector and 12 years as Chairman of Spotlight Group.

Hans Bohlin, Board member & Co-Founder

Inventor of the machine and treatment method with extensive experience in business development, IT, and innovation.

Charlotta Bohlin, Board member

Lawyer with over 30 years of experience in banking, finance, and management.

Axel Bohlin, CSO, Board member & Co-Founder

Extensive experience in communication, digital marketing, business automation, management, and business development.

Ivar Bohlin, CEO & Co-Founder

Extensive experience in sales, business and customer relations, responsible for therapist training since 2019.

Lena Bohlin, CFO

30 years of experience in financial management from Umeå University

Victor Forsell, COO

Entrepreneur with hands-on experience running three clinics with 29 employees, completed an exit in 2022.

John Hedén, VP of Marketing

Over 10 years of experience in startups, sales, entrepreneurship, marketing, management, and IT.

Ulrika Gahm, VP of Communications

More than 10 years of experience in B2C and B2B communication, PR, marketing, and campaign management.

Oscar Strålin, Auditor

Experienced Certified Auditor, Grant Thornton

Anders Fernlund

Expert in Franchise Law

Branko Lazarevic

Franchise Growth Specialist

Brad Martineau

Business Automation Expert

Fredrik Ekblom

Strategic Advisor